Suramin Inhibits Gonadotropin Action In Rat Testis: Implications For Treatment Of Advanced Prostate Cancer-Reference-Cited by-同舟云学术

Suramin Inhibits Gonadotropin Action In Rat Testis: Implications For Treatment Of Advanced Prostate Cancer

Published:1992-03 Issue:3 Part 1 Volume:147 Page:727-732
ISSN:0022-5347
Container-title:Journal of Urology
language:en
Short-container-title:Journal of Urology

Author:

Daugherty Rhett L.¹,Cockett Abraham T.K.¹,Schoen Susan R.¹,Sluss Patrick M.¹

Affiliation:

1. From the Department of Urology, University of Rochester, Rochester, New York

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Urology

Reference35 articles.

1. Suramin inhibition of growth factor receptor binding and mitogenicity in AKR-2B cells;Coffey;J. Cell Physiol,1987

2. Suramin inhibits binding and degra dation of platelet-derived growth factor in arterial smooth muscle cells but does not interfere with autocrine stimulation of DNA synthesis;Sjolund;Cell Tissue Res.,1989

3. Clinical pharmacokinetics of suramin in patients with HTLV-III/LAV infection;Collins;J. Clin. Pharmacol.,1986

4. Suramin in adrenal cancer: modulation of steroid hormone production, cytotoxicity in vitro, and clinical antitumor effect;LaRocca;J. Clin. Endo. Metab.,1990

5. Use of suramin in treatment of prostatic carcinoma refractory to conventional hormonal manipulations;LaRocca;Urol. Clin. N. Am.,1991

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Follicle-stimulating hormone promotes nerve growth factor and vascular endothelial growth factor expression in epithelial ovarian cells;HISTOL HISTOPATHOL;2020

2. Small Molecule Follicle-Stimulating Hormone Receptor Agonists and Antagonists;Frontiers in Endocrinology;2019-01-23

3. FSH Receptor Signaling: Complexity of Interactions and Signal Diversity;Endocrinology;2018-07-03

4. Gonadotropins and Their Analogs: Current and Potential Clinical Applications;Endocrine Reviews;2018-07-02

5. Ekspresja receptorów hormonu dojrzewania pęcherzyków w naczyniach wewnątrzguzowych i komórkach nowotworowych — udział w progresji guzów i perspektywy zastosowania w diagnozie i terapii raka;Endokrynologia Polska;2018-03-29